Categories
Health

Immunotherapy May Not Benefit All Gastroesophageal Cancer Patients, FDA Staff Says

Source link : https://www.newshealth.biz/health-news/immunotherapy-may-not-benefit-all-gastroesophageal-cancer-patients-fda-staff-says/

An FDA advisory committee will consider whether PD-L1 expression cutoffs should guide use of checkpoint inhibitors to treat advanced gastroesophageal cancers. Current approved indications for three different PD-1/PD-L1 inhibitors allow use of the drugs in advanced gastroesophageal cancers irrespective of PD-L1 expression levels. FDA staff reports suggest the agency might want to rethink those approvals […]

Author : News Health

Publish date : 2024-09-24 20:25:24

Copyright for syndicated content belongs to the linked Source.

..........................%%%...*...........................................$$$$$$$$$$$$$$$$$$$$--------------------.....